Fort Wayne, IN—Vera Bradley Inc. reported Wednesday afternoon that its second quarter profit rose 12%, but lowered its full year forecast disappointed analysts and drove down the company’s stock price.
For the quarter ended August 3, the handbag and accessories company posted earnings of $14.95 million, or 37 cents a share, compared with earnings of $13.37 million, or 33 cents a share, a year ago. Analysts’ average estimate expected 32 cents a share.
Net sales were up 2% to $125.4 million, compared to analysts’ estimate for $124.7 million in sales.
An ‘Uncertain Consumer Environment’
Sales in Vera Bradley’s direct segment rose 14% to $75 million. Its retail stores posted a 24% increase due mostly to the addition of 20 full price and four outlet stores in the last year. Comparable store sales were down, however, due to weaker sales resulting from reduced traffic.
Online revenue rose 1.4% “due to continued growth in website traffic, offset by reduced conversion.” Indirect sales to the company’s wholesale accounts were down 12% to $50.4 million as retailers pulled back on orders.
“We managed through considerable headwinds in the second quarter, yet delivered results in line with our expectations,” said Michael C. Ray, chief executive. “Nonetheless, our product offering underperformed in the midst of an uncertain consumer environment, which affected traffic in our retail stores.”
Despite the second quarter increases, the company took a “cautious outlook for the remainder of the year.”
For its third quarter, Vera Bradley now expects earnings in the range of 33 cents to 35 cents a share on sales in the range of $128 million to $130 million. But analysts’ average estimate had expected earnings of 48 cents a share on sales of $146.6 million.
The company also reduced its fiscal full year forecast well below what analysts expected. Now Vera Bradley forecast full year earnings between $1.47 to $1.52 a share on sales ranging from $535 million to $540 million. Analysts, however, look for earnings of $1.71 a share on revenue of $571.4 million.
For commercial purposes, extract supplements can be obtained from the fruit of the pericarp. Garcinia cambogia reviews is performed by a physician Chen and Oz to prove that it is an herb for weight loss, a lot of research has been done. Studies, Garcinia cambogia extract supplementation decreases the weight of the body fat accumulation, was shown to have a positive effect on prevention. We are important substances such as cholesterol (LDL), reduces the serum leptin and triglycerides. In addition, it will increase the level of serotonin and cholesterol (HDL). The study also, Garcinia cambogia extract supplements, has proven that there are no significant adverse effects on many of the eight weeks, such as its use.